Related Experiment Video
Updated: Aug 15, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Research Progress of H2S Donors Conjugate Drugs Based on ADTOH
Shuai Wen1, Changchang Cao1, Jianwen Ge1
1College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China.
Abstract:
H2S is an endogenous gas signaling molecule and its multiple biological effects have been demonstrated. The abnormal level of H2S is closely related to the occurrence and development of many diseases, and H2S donors has important pharmacological implications. In recent years, H2S donors represented by ADTOH (5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione) are often used to synthesize new 'conjugate' compounds that can release H2S and parent drugs. These hybrids retain the pharmacological activity of the parent drugs and H2S and have a synergistic effect. ADTOH and parent drug hybrids have become one of the important strategies for the development of H2S donor conjugate drugs. This review summarizes molecular hybrids between ADTOH and clinical drugs to provide new ideas for the study of H2S donor drug design.
Related Concept Videos
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Drug Metabolism: Phase II Reactions
Preparation and Reactions of Thiols
Phase II Conjugation Reactions: Overview
Preparation and Reactions of Sulfides

